Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- OHSU Knight Cancer Institute
- Study ID
- NCT04890054
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Fecal Immunochemical Test — OTHERPatients due for CRC screening are mailed a FIT test by the clinic or health plan
- Interview — OTHERParticipate in interviews to evaluate the implementation of the mailed FIT and patient navigation programs by the clinics and regional organizations
- Patient Navigation — BEHAVIORALClinic staff are trained in Navigation, patients with an abnormal FIT are contacted about colonoscopy by patient navigators
Study Details
This study collects information to provide a model for how to rapidly adapt and scale-up multilevel interventions through clinic-health plan partnerships to reduce the burden of colorectal cancer (CRC) on the United states population. This study may improve colorectal cancer screening rates, follow-up colonoscopy, and referral to care in rural Medicaid patients.
Key Dates
- Start date
- May 14, 2021
- Status verified
- Jul 2025
- Primary completion
- Jul 1, 2024
- Completion
- Jul 1, 2024
Study Design
- Enrollment
- 5,696 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Active Comparator: SMARTER CRC Intervention Year 1In year 1, patients receive mailed FITs from CCO, screening reminders from clinics, and patient navigation as appropriate; Health record data collected.
- No Intervention: SMARTER CRC Usual CareUsual clinical care
Primary Outcome Measure
Likelihood of Any Colorectal Cancer (CRC) Screening (for Study-eligible Patients) [ Time Frame: Primary outcome at 6 months following CCO eligible patient list pull date, ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OHSU Knight Cancer Institute | Portland | Oregon | 97239 | - |
Find similar trials in Portland, OR
By condition
By specialty
By research site
Related Studies
- A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPHASE1 · Recruiting · AstraZeneca · Gilbert, Arizona
- Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPHASE1 · Recruiting · AstraZeneca · Duarte, California
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruiting · Wake Forest University Health Sciences · Fairbanks, Alaska
- Collection of Information to Better Understand Young Onset Colorectal CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey